This patent teaches the transfection of bone marrow stem cells using a new type of vector. The vector disclosed is an alphavirus vector. Transfection by alphavirus has been performed in numerous situations and is actually in clinical trials.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.